W. Richard Staub
Vermögen: 3 Mio $ am 31.05.2026
Vermögen: 3 Mio $ am 31.05.2026
Derzeit ist W. Richard Staub President-Research & Development Solutions bei IQVIA Holdings, Inc. Er ist außerdem im Vorstand von TLC Operations, Inc. In seiner früheren Laufbahn war W. Staub Marketing Manager bei Zeneca Pharmaceuticals, President, Chief Executive Officer & Director bei Novella Clinical, Inc. und Senior Vice President-Global Business Development bei Pharmaceutical Product Development LLC. W. Richard Staub erwarb einen Bachelor-Abschluss an der University of North Carolina in Charlotte.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IQVIA HOLDINGS INC 0,01 % | 09.02.2026 | 18.812 ( 0,01 % ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IQVIA HOLDINGS INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.09.2023 |
TLC Operations, Inc.
TLC Operations, Inc. Personnel ServicesCommercial Services Provides cognitive disability and dev disability services | Direktor/Vorstandsmitglied | - |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Private Equity Investor | 01.10.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Novella Clinical, Inc.
Novella Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research development solutions | Vorstandsvorsitzender | 01.01.2013 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Corporate Officer/Principal | 01.01.2004 |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Vertrieb & Marketing | 01.01.1997 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TLC Operations, Inc.
TLC Operations, Inc. Personnel ServicesCommercial Services Provides cognitive disability and dev disability services | Commercial Services |
Novella Clinical, Inc.
Novella Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research development solutions | Commercial Services |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
IQVIA Holdings, Inc.
IQVIA Holdings, Inc. BiotechnologyHealth Technology Provides outsourced clinical research and trial, mission critical information, technology, healthcare and patient engagement services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen